Stoke Therapeutics (STOK)
(Real Time Quote from BATS)
$12.41 USD
+0.15 (1.22%)
Updated Sep 27, 2024 12:02 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (87 out of 251)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.37 | 9.99 |
Current Quarter Estimate | -0.52 | 3.00 | 61.00 |
Year Ago Quarter Estimate | -0.55 | -4.79 | 54.84 |
Next Quarter Estimate | -0.56 | 3.82 | 63.00 |
Next Year Estimate | -2.59 | 24.58 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 11.76 | 17.70 | 15.67 |
Next Year | -23.33 | 9.90 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.95 |
Price/Book (MRQ) | 2.63 | 2.05 |
Price/Cash Flow (MRFY) | NA | 16.44 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -683.35% | -154.18% |
Return on Equity (TTM) | -57.89% | -61.34% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.